Page - (000206) - in Biomedical Chemistry: Current Trends and Developments

Journal of Neuroscience, 21(20), 8154-8163. Saransaari, P. and S. S. Oja (1992). Release of GABA and taurine from brain slices. Progress in Neurobiology, 38(5), 455-482. Schafer, D. P., E. K. Lehrman, et al. (2013). The “quad-partite” synapse: microglia-synapse interactions in the developing and mature CNS. Glia, 61(1), 24-36. Schindler, K. A., S. Bialonski, et al. (2008). Evolving functional network properties and synchronizability during human epileptic seizures. Chaos, 18(3), 033119. Schramm, N. L., R. E. Egli, et al. (2002). LTP in the mouse nucleus accumbens is developmentally regulated. Synapse, 45(4), 213-219. Schuske, K., A. A. Beg, et al. (2004). The GABA nervous system in C. elegans. Trends in Neurosciences, 27(7), 407-414. Schwartz-Bloom, R. D. and R. Sah (2001). Gamma-Aminobutyric acid(A) neurotransmission and cerebral ischemia. Journal of Neurochemistry, 77(2), 353-371. Scott, H. A., F. M. Gebhardt, et al. (2011). Glutamate transporter variants reduce glutamate uptake in Alzheimer’s disease. Neurobiology of Aging, 32(3), 553 e551-511. Selkoe, D. J. (2002). Alzheimer’s disease is a synaptic failure. Science, 298(5594), 789-791. Sellings, L. H. and P. B. Clarke (2003). Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core. The Journal of Neuroscience, 23(15), 6295-6303. Serra, H. G., C. E. Byam, et al. (2004). Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice. Human Molecular Genetics, 13(20), 2535-2543. Seyedabadi, M., G. Fakhfouri, et al. (2014). The role of serotonin in memory: interactions with neurotransmitters and downstream signaling. Experimental Brain Research, 232(3), 723-738. Shimizu, K., K. Matsubara, et al. (2003). Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture. Neuroscience Research, 46(4), 523-532. Shimo, Y. and T. Wichmann (2009). Neuronal activity in the subthalamic nucleus modulates the release of dopamine in the monkey striatum. The European Journal of Neuroscience, 29(1), 104-113. Sims, N. R. and E. Zaidan (1995). Biochemical changes associated with selective neuronal death following short-term cerebral ischaemia. International Journal of Biochemistry & Cellular Biology, 27(6), 531-550. Singer, A. C. and L. M. Frank (2009). Rewarded outcomes enhance reactivation of experience in the hippocampus. Neuron, 64(6), 910-921. Snyder, E. M., Y. Nong, et al. (2005). Regulation of NMDA receptor trafficking by amyloid-beta. Nature Neuroscience, 8(8), 1051-1058. Sokolow, S., S. H. Luu, et al. (2012). Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer’s disease cortex. Neurobiology of Disease, 45(1), 381-387. Steinbusch, H. W. (1981). Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience, 6(4), 557-618. Stockmeier, C. A. (2003). Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. Journal of Psychiatric Research, 37(5), 357-373.